Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Capital Expenditures (2017 - 2025)

Historic Capital Expenditures for STRATA Skin Sciences (SSKN) over the last 11 years, with Q3 2025 value amounting to $1.0 million.

  • STRATA Skin Sciences' Capital Expenditures rose 154193.55% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 4175.44%. This contributed to the annual value of $1.6 million for FY2024, which is 6740.39% down from last year.
  • According to the latest figures from Q3 2025, STRATA Skin Sciences' Capital Expenditures is $1.0 million, which was up 154193.55% from -$61000.0 recorded in Q2 2025.
  • STRATA Skin Sciences' 5-year Capital Expenditures high stood at $1.8 million for Q1 2023, and its period low was -$194000.0 during Q3 2023.
  • For the 5-year period, STRATA Skin Sciences' Capital Expenditures averaged around $800000.0, with its median value being $726000.0 (2021).
  • In the last 5 years, STRATA Skin Sciences' Capital Expenditures tumbled by 13681.21% in 2023 and then skyrocketed by 154193.55% in 2025.
  • Over the past 5 years, STRATA Skin Sciences' Capital Expenditures (Quarter) stood at $1.1 million in 2021, then soared by 50.35% to $1.7 million in 2022, then grew by 1.12% to $1.7 million in 2023, then tumbled by 70.66% to $504000.0 in 2024, then surged by 101.98% to $1.0 million in 2025.
  • Its Capital Expenditures was $1.0 million in Q3 2025, compared to -$61000.0 in Q2 2025 and $199000.0 in Q1 2025.